Pneumocystis jirovecii in immunocompromised patients with rheumatic diseases. / Pneumocystis jirovecii en pacientes inmunocomprometidos con enfermedades reumáticas.
Reumatol Clin (Engl Ed)
; 17(5): 290-296, 2021 May.
Article
em En, Es
| MEDLINE
| ID: mdl-32466869
ABSTRACT
Infections, including opportunistic infections, are a major and frequent cause of morbidity and mortality in patients with systemic autoimmune and rheumatic diseases. Pneumocystis jirovecii pneumonia, classically considered to be typical of HIV patients, transplanted patients or patients treated with oncological chemotherapy, is appearing increasingly frequently in these patients. Therefore, rheumatologists should know its mechanism of production, clinical manifestations, treatment and prophylaxis, all of which are addressed in this review.
Texto completo:
1
Bases de dados:
MEDLINE
Idioma:
En
/
Es
Revista:
Reumatol Clin (Engl Ed)
Ano de publicação:
2021
Tipo de documento:
Article